Change - Announcement of Appointment :: Appointment of Non-Independent Non-Executive Chairman
BackDec 02, 2025
| Announcement Title | Change - Announcement of Appointment |
| Date & Time of Broadcast | Dec 2, 2025 20:57 |
| Status | New |
| Announcement Sub Title | Appointment of Non-Independent Non-Executive Chairman |
| Announcement Reference | SG251202OTHR1Z4P |
| Submitted By (Co./ Ind. Name) | Goh Xun Er |
| Designation | Company Secretary |
| Description (Please provide a detailed description of the event in the box below) | Appointment of Non-Independent Non-Executive Chairman of the Company |
| Additional Details | |
| Date of appointment | 02/12/2025 |
| Name of person | Wu Gang |
| Age | 48 |
| Country of principal residence | China |
| The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process) | The Board, having considered the recommendation of the Nominating Committee, as well as the academic and professional qualifications, expertise, working experience and knowledge of Mr. Wu Gang ("Mr. Wu"), is satisfied that Mr. Wu possesses the requisite competencies and experience to assume the responsibilities of Non-Independent Non-Executive Chairman of the Company. In this regard, the Board recognised that the Company is presently navigating operational challenges and effective and steady leadership is essential at this juncture. As such, taking into account that Mr. Wu has held multiple chairmanships and directorships across various sectors, such as retail, healthcare, and commercial management, demonstrating a strong track record in corporate governance and strategic management, the Board believes his appointment can steward the Company towards stability and future growth. |
| Whether appointment is executive, and if so, the area of responsibility | Non-Executive |
| Job title (e.g. Lead ID, AC Chairman, AC Member etc.) | Non-Independent Non-Executive Chairman; and Member of the Nominating Committee |
| Professional qualifications | Master's Degree, University of North Carolina, United States |
| Working experience and occupation(s) during the past 10 years | 2025 to Present - Vice Chairman and Executive President, Sanpower Group 2025 to Present - Chairman of the Board, Dendreon Pharmaceuticals LLC 2024 to Present - Director, Nanjing Xinjiekou Department Store Co., Ltd 2024 to Present - Director, Natali Healthcare Solutions Ltd. 2019 to Present - Chairman and Executive President, Sanpower Retail and Technology 2019 to Present - Chairman, Sanpower Healthcare Industry Management Group 2019 to Present - Chairman, Sanpower Commercial Management Group 2019 to Present - Director, Wangfujing Group Co., Ltd. 2017 to 2019 - Senior Vice President, Sanpower Group 2014 to 2017 - Vice President, Sanpower Group |
| Shareholding interest in the listed issuer and its subsidiaries | No |
| Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries | Mr. Wu holds various leadership roles within Nanjing Xinjiekou Department Store Co., Ltd ("NXDSCL"), Sanpower Group and its affiliates. Sanpower Group Corporation held 35.99% equity interest in NXDSCL, a substantial shareholder of the Company. Sanpower Group Corporation is therefore deemed to be interested in the shares held by NXDSC. |
| Conflict of interest (including any competing business) | No |
| Undertaking (in the format set out in Appendix 7.7 or Appendix 7H) under Mainboard Rule 720(1) or Catalist Rule 720(1) has been submitted to the listed issuer | Yes |
| Other Principal Commitments* Including Directorships# * "Principal Commitments" has the same meaning as defined in the Code of Corporate Governance. # These fields are not applicable for announcements of appointments pursuant to Mainboard Rule 704(9) or Catalist Rule 704(8). |
|
| Past (for the last 5 years) | N/A |
| Present | 2025 to Present - Vice Chairman and Executive President, Sanpower Group 2025 to Present - Chairman of the Board, Dendreon Pharmaceuticals LLC 2024 to Present - Director, Nanjing Xinjiekou Department Store Co., Ltd 2024 to Present - Director, Natali Healthcare Solutions Ltd. 2019 to Present - Chairman and Executive President, Sanpower Retail and Technology 2019 to Present - Chairman, Sanpower Healthcare Industry Management Group 2019 to Present - Chairman, Sanpower Commercial Management Group 2019 to Present - Director, Wangfujing Group Co., Ltd. |
| Information Required Disclose the following matters concerning an appointment of director, chief executive officer, chief financial officer, chief operating officer, general manager or other officer of equivalent rank. If the answer to any question is "yes", full details must be given. (a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? |
No |
| (b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | No |
| (c) Whether there is any unsatisfied judgment against him? | No |
| (d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | No |
| (e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | No |
| (f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | No |
| (g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | No |
| (h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | No |
| (i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| (j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of:- | |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? |
No |
| (k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Disclosure applicable to the appointment of director only. Any prior experience as a director of an issuer listed on the Exchange? |
No |
| If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange. | Mr. Wu will be attending training on the roles and responsibilities of a Director of a listed issuer as prescribed by the Exchange. |
| Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable). | N/A |